Insurance Status and Hospital Payer Mix Are Linked With Variation in Metastatic Site Resection in Patients With Advanced Colorectal Cancers

Diseases of the Colon and Rectum - United States
doi 10.1097/dcr.0000000000000684
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Outcomes of Resection and Non-Resection Strategies in Management of Patients With Advanced Colorectal Cancer

World Journal of Surgical Oncology
SurgeryOncology
2009English

Different Metastatic Pattern According to the KRAS Mutational Status and Site-Specific Discordance of KRAS Status in Patients With Colorectal Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2012English

Perioperative Chemotherapy With or Without Bevacizumab in Patients With Metastatic Colorectal Cancer Undergoing Liver Resection

Clinical Colorectal Cancer
OncologyGastroenterology
2013English

Bevacizumab Improves Survival in Metastatic Colorectal Cancer Patients With Primary Tumor Resection: A Meta-Analysis

Scientific Reports
Multidisciplinary
2019English

PTEN Status in Advanced Colorectal Cancer Treated With Cetuximab

British Journal of Cancer
Cancer ResearchOncology
2009English

Pretreatment Immune Status Correlates With Progression-Free Survival in Chemotherapy-Treated Metastatic Colorectal Cancer Patients

Cancer immunology research
Cancer ResearchImmunology
2016English

Surveillance for Multicentric Colorectal Cancers and Other Primary Cancers in Patients With Curative Surgery for Colorectal Cancer

Nippon Daicho Komonbyo Gakkai Zasshi
2006English

Are Proximal Colorectal Cancers Always Associated With Distal Adenomas?

Gut
Gastroenterology
2003English

Major Surgery in Patients With Metastatic Colorectal Cancer in Western Europe

Journal of Gastrointestinal Cancer
OncologyGastroenterology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy